ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Institute Funds 24 DNA Microarray Centers

September 24, 1999

Nominations Sought For Paul Marks Prizes, Recognizing Discoverise By The Under-45 Set.

April 13, 2001

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

June 20, 2008

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

Funding Opportunities (8-page issue).

April 25, 2003

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002